{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:02:55Z","timestamp":1789448575777,"version":"build-2803163510"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    CRC is the third most prevalent malignancy worldwide and the second leading cause of cancer-related mortality. According to GLOBOCAN 2022 estimates, approximately 1.93 million new CRC cases and 900,000 CRC-related deaths occur annually worldwide. Incidence rates continue to rise in developing countries, driven by the westernization of dietary patterns, sedentary lifestyles, and increasing obesity prevalence, with a notable trend toward younger-onset disease. In recent years, mounting evidence has implicated the microbiota as a critical contributor to CRC initiation and progression. Distinct from the fecal microbiome, the intratumoral microbiome constitutes an independent, low-biomass microbial community predominantly composed of bacteria, with additional fungal, viral, and archaeal components. Microbial communities within the TME promote CRC development and progression by modulating host immune responses, metabolic pathways, and tumor cell proliferation and metastasis.\n                    <jats:italic>Fusobacterium nucleatum<\/jats:italic>\n                    , ETBF, polyketide synthase genotoxicity island-harboring\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    and\n                    <jats:italic>Parvimonas micra<\/jats:italic>\n                    represent the most well-substantiated candidate oncomicrobes, whose carcinogenic activities involve multiple intertwined pathways, including chronic inflammation, genotoxic DNA damage, immune evasion, metabolic reprogramming, and non-coding RNA regulation. Furthermore, intratumoral microbiota may serve as early diagnostic biomarkers for CRC, offer novel therapeutic targets, and provide potential biological rationale for prognostic prediction. Microbiome-based diagnostic biomarkers, such as multi-bacterial fecal\/tissue panels, have demonstrated sensitivity comparable to or superior to the fecal immunochemical test in select retrospective cohorts; however, large-scale, multicenter, prospective validation remains necessary. Strategies targeting intratumoral bacteria \u2014 including antibiotics, bacteriophages, phage-guided nanocarriers, and FMT \u2014 remain predominantly in the preclinical stage. Although phase I\/II trials of FMT for immunotherapy sensitization have yielded encouraging results, small sample sizes and substantial heterogeneity preclude its near-term adoption as a standard-of-care recommendation. This review systematically summarizes the latest advances in understanding the relationship between intratumoral microbiota and CRC, critically appraises the strength of evidence across different hierarchical levels, evaluates the consistency and controversies surrounding major mechanistic hypotheses, addresses methodological challenges inherent to low-biomass microbiome research, and discusses the translational potential in CRC diagnosis, therapy, and prognostic prediction.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1832875","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:48Z","timestamp":1789446408000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral microbiota: implications for colorectal cancer pathogenesis and therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Junhong","family":"Liu","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Gansu University of Traditional Chinese Medicine","place":["Lanzhou, China"]},{"name":"Gansu University of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Qi","sequence":"additional","affiliation":[{"name":"Gansu University of Traditional Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00044-9","article-title":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s43657-025-00270-5","article-title":"Large-scale searching for causal relationships of body mass index bridged modifiable lifestyle factors on colorectal cancer risk: A phenome-wide Mendelian randomization study","author":"Shao","year":"2026","journal-title":"Phenomics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","article-title":"Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver","volume":"39","author":"Bertocchi","year":"2021","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43657-023-00131-z","article-title":"Human gut microbiome researches over the last decade: current challenges and future directions","volume":"5","author":"Wu","year":"2025","journal-title":"Phenomics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-023-01693-0","article-title":"Intratumoural microbiota: a new frontier in cancer development and therapy","volume":"9","author":"Cao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202100252","article-title":"Cancer\u2019s second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution","volume":"44","author":"Sepich-Poore","year":"2022","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200470","article-title":"Microbiota in tumors: From understanding to application","volume":"9","author":"Xie","year":"2022","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810928","article-title":"The relationship of tumor microbiome and oral bacteria and intestinal dysbiosis in canine mammary tumor","volume":"23","author":"Zheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01607-23","article-title":"Major data analysis errors invalidate cancer microbiome findings","volume":"14","author":"Gihawi","year":"2023","journal-title":"mBio"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aal5240","article-title":"Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer","volume":"358","author":"Bullman","year":"2017","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207002","article-title":"Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer","volume":"13","author":"Shah","year":"2018","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/gutjnl-2017-314219","article-title":"Tumour-associated and non-tumour-associated microbiota in colorectal cancer","volume":"67","author":"Omar Al-Hassi","year":"2018","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1920657","article-title":"Mapping the colorectal tumor microbiota","volume":"13","author":"Murphy","year":"","journal-title":"Gut Microbes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.787176","article-title":"Colorectal cancer-associated microbiome patterns and signatures","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.03.205","article-title":"Oncomicrobial community profiling identifies clinicomolecular and prognostic subtypes of colorectal cancer","volume":"165","author":"Mouradov","year":"2023","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30168","article-title":"Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway","volume":"139","author":"Yu","year":"2016","journal-title":"Int J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/gr.126573.111","article-title":"Genomic analysis identifies association of Fusobacterium with colorectal carcinoma","volume":"22","author":"Kostic","year":"2012","journal-title":"Genome Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-16","article-title":"Co-occurrence of anaerobic bacteria in colorectal carcinomas","volume":"1","author":"Warren","year":"2013","journal-title":"Microbiome"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017221","article-title":"Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers","volume":"98","author":"Chen","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11864-021-00870-z","article-title":"Beyond microsatellite instability: Evolving strategies integrating immunotherapy for microsatellite stable colorectal cancer","volume":"22","author":"Pecci","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s43657-024-00202-9","article-title":"A EPCAM pathogenic variant in familial Lynch syndrome-associated colon cancer: Insights into genetic basis and tumor microenvironment characteristics","volume":"5","author":"Wang","year":"2025","journal-title":"Phenomics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0174","article-title":"Fusobacterium nucleatum in colorectal cancer relates to immune response differentially by tumor microsatellite instability status","volume":"6","author":"Hamada","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2018.11.29","article-title":"Prognostic impact of Fusobacterium nucleatum depends on combined tumor location and microsatellite instability status in stage II\/III colorectal cancers treated with adjuvant chemotherapy","volume":"53","author":"Oh","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-01030-7","article-title":"Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts","volume":"7","author":"Liu","year":"2022","journal-title":"Nat Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292551","article-title":"Gut microbiota profiles in feces and paired tumor and non-tumor tissues from colorectal cancer patients. Relationship to the body mass index","volume":"18","author":"Tesolato","year":"2023","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.020","article-title":"Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215350","article-title":"The role of Fusobacterium nucleatum in colorectal cancer cell proliferation and migration","volume":"14","author":"Wu","year":"2022","journal-title":"Cancers"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100920","article-title":"Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtype","volume":"4","author":"Younginger","year":"2023","journal-title":"Cell Rep Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.07.006","article-title":"Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc","volume":"20","author":"Abed","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah3648","article-title":"Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria","volume":"359","author":"Dejea","year":"2018","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00594-2","article-title":"Bacteria in cancer initiation, promotion and progression","volume":"23","author":"El Tekle","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","article-title":"Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-Like Receptor 4 signaling to Nuclear Factor-\u03baB, and up-regulating expression of MicroRNA-21","volume":"152","author":"Yang","year":"2017","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1757513","article-title":"Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1713614","article-title":"Microbiota-host metabolism reprogramming in colorectal cancer: from pathogenesis to precision therapies","volume":"15","author":"Guo","year":"2025","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13099-025-00757-6","article-title":"Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer","volume":"17","author":"Sadeghloo","year":"2025","journal-title":"Gut Pathog"},{"key":"B45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41522-025-00883-8","article-title":"Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming","volume":"12","author":"Bautista","year":"2026","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0085-5","article-title":"Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A","volume":"12","author":"Chan","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.chom.2021.08.013","article-title":"Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer","volume":"29","author":"Kordahi","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091256","article-title":"Proinflammatory and cancer-promoting pathobiont Fusobacterium nucleatum directly targets colorectal cancer stem cells","volume":"12","author":"Cavallucci","year":"2022","journal-title":"Biomolecules"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03455","article-title":"Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage","volume":"120","author":"Wu","year":"2007","journal-title":"J Cell Sci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2249.2002.01921.x","article-title":"Nuclear factor-kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin","volume":"130","author":"Kim","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.10.5832-5839.2004","article-title":"Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway","volume":"72","author":"Wu","year":"2004","journal-title":"Infect Immun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/science.1206095","article-title":"The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003617","article-title":"Intestinal dysbiosis and colorectal cancer","volume":"138","author":"Kang","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00203-024-03834-7","article-title":"Butyrate\u2019s (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer","volume":"206","author":"Karim","year":"2024","journal-title":"Arch Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01588","article-title":"Toll-like receptor 2-mediated suppression of colorectal cancer pathogenesis by polysaccharide A from Bacteroides fragilis","volume":"9","author":"Sittipo","year":"2018","journal-title":"Front Microbiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05038-22","article-title":"Multi-omics analysis reveals intratumor microbes as immunomodulators in colorectal cancer","volume":"11","author":"Liu","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.01.024","article-title":"Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial","volume":"183","author":"Hilmi","year":"2023","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3827","article-title":"Porphyromonas gingivalis promotes colorectal carcinoma by activating the hematopoietic NLRP3 inflammasome","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105320","article-title":"Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22","volume":"40","author":"Zhu","year":"2021","journal-title":"EMBO J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-0453","article-title":"Fusobacterium nucleatum promotes the development of colorectal cancer by activating a cytochrome P450\/epoxyoctadecenoic acid axis via TLR4\/Keap1\/NRF2 signaling","volume":"81","author":"Kong","year":"2021","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.1377","article-title":"Fusobacterium nucleatum and T cells in colorectal carcinoma","volume":"1","author":"Mima","year":"2015","journal-title":"JAMA Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.chom.2023.01.013","article-title":"Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance","volume":"31","author":"Zhang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192282","article-title":"Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling","volume":"217","author":"Shi","year":"2020","journal-title":"J Exp Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12469","article-title":"Bifidobacterium adolescentis orchestrates CD143+ cancer\u2010associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling\u2010regulated GAS1","volume":"43","author":"Chen","year":"2023","journal-title":"Cancer Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12964-023-01425-5","article-title":"Intratumoral microorganisms in tumors of the digestive system","volume":"22","author":"Xuan","year":"2024","journal-title":"Cell Commun Signal CCS"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310101","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis","volume":"65","author":"Mima","year":"2016","journal-title":"Gut"},{"key":"B67","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/s41467-021-26352-2","article-title":"Regulatory T cells promote cancer immune-escape through integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation","volume":"12","author":"Lain\u00e9","year":"2021","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09913-z","article-title":"Microbiota-induced T cell plasticity enables immune-mediated tumour control","volume":"651","author":"Najar","year":"2026","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126262","article-title":"Metabolic reprogramming of colorectal cancer cells and the microenvironment: Implication for therapy","volume":"22","author":"Nenkov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322780","article-title":"F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer","volume":"70","author":"Hong","year":"2021","journal-title":"Gut"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2273","article-title":"ANGPTL4-mediated promotion of glycolysis facilitates the colonization of Fusobacterium nucleatum in colorectal cancer","volume":"81","author":"Zheng","year":"2021","journal-title":"Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2017.01.009","article-title":"Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice","volume":"152","author":"Tsoi","year":"2017","journal-title":"Gastroenterology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2021.12.001","article-title":"Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance","volume":"40","author":"Bell","year":"2022","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081632","article-title":"Clinical role of ASCT2 (SLC1A5) in KRAS-mutated colorectal cancer","volume":"18","author":"Toda","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","article-title":"A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells","volume":"31","author":"Yoo","year":"2020","journal-title":"Cell Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","article-title":"Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer","volume":"31","author":"Jiang","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010203108","article-title":"Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis","volume":"108","author":"Goodwin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol Cell"},{"key":"B80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s43657-024-00193-7","article-title":"Precision dietary intervention: Gut microbiome and meta-metabolome as functional readouts","volume":"5","author":"Luo","year":"2025","journal-title":"Phenomics"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02554-x","article-title":"Intratumoral presence of the genotoxic gut bacteria pks+ E. coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer","volume":"130","author":"Joo","year":"2024","journal-title":"Br J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1038\/s41467-023-43329-5","article-title":"Contribution of pks+ E. coli mutations to colorectal carcinogenesis","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7785","article-title":"The human gut bacterial genotoxin colibactin alkylates DNA","volume":"363","author":"Wilson","year":"2019","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127059","article-title":"Escherichia coli induces DNA double-strand breaks in eukaryotic cells","volume":"313","author":"Nougayr\u00e8de","year":"2006","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41557-019-0317-7","article-title":"Macrocyclic colibactin induces DNA double-strand breaks via copper-mediated oxidative cleavage","volume":"11","author":"Li","year":"2019","journal-title":"Nat Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu787","article-title":"The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients","volume":"60","author":"Boleij","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","article-title":"Enterotoxigenic Bacteroidesfragilis promotes intestinal inflammation and Malignancy by inhibiting exosome-packaged miR-149-3p","volume":"161","author":"Cao","year":"2021","journal-title":"Gastroenterology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41419-019-1925-2","article-title":"Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB\/mTOR pathway","volume":"10","author":"Bao","year":"2019","journal-title":"Cell Death Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305257","article-title":"Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype","volume":"63","author":"Cougnoux","year":"2014","journal-title":"Gut"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310520","article-title":"Cross-kingdom interaction of miRNAs and gut microbiota with non-invasive diagnostic and therapeutic implications in colorectal cancer","volume":"24","author":"P\u00f6s","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12943-015-0450-x","article-title":"Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells","volume":"14","author":"Hu","year":"2015","journal-title":"Mol Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02572-2","article-title":"Parvimonas micra activates the Ras\/ERK\/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression","volume":"42","author":"Chang","year":"2023","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B96","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106770","article-title":"MicroRNA-31 induced by Fusobacterium nucleatum infection promotes colorectal cancer tumorigenesis","volume":"26","author":"Tang","year":"2023","journal-title":"iScience"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107686","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis by excretion of miR-122-5p from cells via exosomes","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321187","article-title":"Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246\/92b-3p\/27a-3p and CXCL16","volume":"10","author":"Guo","year":"2020","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwad052","article-title":"Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets","volume":"15","author":"Dai","year":"2024","journal-title":"Protein Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.semcancer.2021.11.007","article-title":"Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective","volume":"86","author":"Panebianco","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00547-21","article-title":"Aspirin modulation of the colorectal cancer-associated microbe Fusobacterium nucleatum","volume":"12","author":"Brennan","year":"2021","journal-title":"mBio"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab017","article-title":"Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response","volume":"45","author":"Kabwe","year":"2021","journal-title":"FEMS Microbiol Rev"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0423-2","article-title":"Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy","volume":"3","author":"Zheng","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.058","article-title":"Therapeutic potential of fecal microbiota transplantation","volume":"145","author":"Smits","year":"2013","journal-title":"Gastroenterology"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2017.1290757","article-title":"Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease","volume":"8","author":"Weingarden","year":"2017","journal-title":"Gut Microbes"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2017.09.016","article-title":"Wild mouse gut microbiota promotes host fitness and improves disease resistance","volume":"171","author":"Rosshart","year":"2017","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874922","article-title":"Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102315","article-title":"Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)","volume":"66","author":"Zhao","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17030306","article-title":"Anti-tumor strategies of photothermal therapy combined with other therapies using nanoplatforms","volume":"17","author":"Xu","year":"2025","journal-title":"Pharmaceutics"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102479","article-title":"Photothermal-triggered non-apoptotic regulated cell death-related pathway regulation boosts systemic antitumor immunity","volume":"35","author":"Liang","year":"2025","journal-title":"Mater Today Bio"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00103.2023","article-title":"Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer","volume":"56","author":"Li","year":"2024","journal-title":"Physiol Genomics"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181595","article-title":"Fusobacterium nucleatum promotes colorectal cancer through neogenesis of tumor stem cells","volume":"135","author":"Wang","year":"2025","journal-title":"J Clin Invest"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2022.08.010","article-title":"Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer","volume":"31","author":"Wang","year":"2023","journal-title":"Trends Microbiol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","article-title":"Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-\u03baB\/S100A9 cascade","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1165790","article-title":"Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3109","article-title":"Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12597","article-title":"Beyond the gut: The intratumoral microbiome\u2019s influence on tumorigenesis and treatment response","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun Lond Engl"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s43657-025-00236-7","article-title":"Relational stability: A new strategy for defining the human core microbiome","volume":"5","author":"Zhao","year":"2025","journal-title":"Phenomics"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott","year":"2019","journal-title":"Gut"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02963-2","article-title":"Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development","volume":"30","author":"Tito","year":"2024","journal-title":"Nat Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s43657-024-00211-8","article-title":"Topology of gut microbiota network and guild-based analysis in Chinese adults","volume":"5","author":"Fu","year":"2025","journal-title":"Phenomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:26:50Z","timestamp":1789446410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2026.1832875"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1832875","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1832875"}}